Rapid SARS-CoV-2 Antigen Card Test

Rapid 2019-nCoV IqG/IqM Combo Tost Cnrd ts nn •mmunoenromatOQraphy esekwe inyathelo elinye in vitro tost It « d<>siQfi©d for tho fuptd Qualitative delmmlnMion of IflG nr>d IflM antitxxJios to 9 novel CoVV SA (20201RS novel coronavirus). -2) kwi-somm yomntu mmA. oc whole btood Rapid 2019-nCoV IgG/IgM Combo Tost Cnrd lubhaqo lwe supplomont ye COVID-19 BKpoctod infectod patents bosidot nudoic nod tost enokuthi ibuhlungu ukuchaneka kwe-cieloction (okanye i-COVID19

USHWANKATHELO

Intsholongwane i-COVID-19 H nnq ukuya kwintsholongwane ye-COVID-19 H nn kwisifo esiyingozi sokuphefumla esingenalwazi Poop«o om Oonocnlly suscoptiWo Okwangoku, ezo zigulana zosulelwe yinoveli coronavirus kunye nomthombo ophambili we-mfoebon. n^ywplomatic mfofofod poog cah Kwakhona ube ngumthombo mfoebous kungokunje ©p

UMGAQO

Ikhadi loVavanyo lwe-Rnpxl 2019-nCoV Combo lisebenzisa i-pnnoplo ye-immuno^nromotoflrap^y. Mqum imbovane>-igM yomntu kunye nempuku mithi igG Aniitxxlies nro immoeniizod kwi tho ntfroceHutose meentxane ngokulandelelanayo, njenge tost tini ezimbini (igM line aM IgG bno) kwifestile yovavanyo yesixhobo sovavanyo Umgca we-IgM tn uvavanyo wndew I-umple well fottowed yi-IgG itnc Njengeyona sampuli incinci ye-ftown kwi-membrane ngaphakathi kwesixhobo sovavanyo lwe-IM i-recomt enemibala ye-2019-nCoV> i-nant 90M ye-conjugate yeefom ze-complexes ezikhethekileyo

ii-nntibodios (IgM an

Ukungabikho kwebhendi ye-tg cokxed kwifestile yovavanyo kubonisa ukuba ne^at/vo isiphumo sovavanyo A bwn-

IZIXHOBO EZINIKEZELWAYO

1 Raprt 2019-nCoV IgG-lgM Combo Test Card

2 Isampulu yesithinteli

2 pL capillary pipet 4 Imiyalelo yokusetyenziswa

IZINTO EZIFUNEKAYO KODWA AKUNIKEZWE

Iwashi okanye i-timer, i-lancets yokhuseleko, i-alcohol prep

UKUGCINA

Gcina isixhobo se-tost kwi-4 ukuya kwi-30 ° C kwi-onflinnl soalod pouch Musa i-Froozo.
Umhla wokuphelelwa ukuba > dicaie
Esona sixhobo sinokuhlala kwisingxobo esitywiniweyo de silungele ukusetyenziswa. Emva kokuvula, isixhobo sovavanyo kufuneka sisetyenziswe ngokukhawuleza. Musa ukuphinda usebenzise isixhobo.

UKULUMKELA

1 Yeyobungcali kwi-vitro diagnostic uso kuphela

2 Imveliso •$ stncUy yobuchwephesha bezonyango u$e kuphela tod 曲 mwoded ukusetyenziswa buqu

3 Musa ukusebenzisa imveliso ngaphaya komhla we-exprsbon

4 Musa imveliso ukuba isingxobo, $ darnaged okanye tM $«ai is itxoken

5 Phatha yonke imizekelo njengenokusuleleka

6 Landela umgangatho weLat> inkqubo aM tMOsafety fluxMhnet kunye nokulahlwa kwe potemiaii/ esosulelayo

imathiriyeli Xa inkqubo yovavanyo igqityiwe, lahla imizekelo emva kokuba i-autoclaving kwi-121P kx ubuncinane i-20 min yokuphatha nge-0 5% ye-Sodium HypochJonte f

UKUQOKELELWA KOMPILO ANO LUNGISELELO

1 Iserum, iplasma okanye isampuli yegazi elipheleleyo kufuneka icoliedod uruSer standard iatxxatory conditions.

2 Ubushushu obungenacvatKX) besampulu, obunokuthi bubangele i-hemolyse kunye neproton denaturation, kufuneka iphetshwe.

3 Uvavanyo lusebenza ngcono kwiisampuli zegazi elipheleleyo / i-serum i plasma Ukuba uvavanyo alunakwenziwa ngokukhawuleza, i-serum I plasma inokugcinwa kwi-2-8 ° C ukuya kwiintsuku ze-3 kwimeko yo (Indlela yokuvavanya ukugcinwa kwexesha elide, i-serum / plasma speamens inokukhenkcezwa ・20*C lor iinyanga ezi-3 okanye ・70°C tef ipenodi ende Kuphephe ukuphindaphinda imijikelo yokukhenkceza/thavwng.

I-4 Sodium az>de inokudityaniswa njengesigcini ukuya kuthi ga kwi-0.1% ngaphandle kokuchaphazela iziphumo zovavanyo.